prednisolone has been researched along with Hormone-Dependent Neoplasms in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to evaluate the efficacy and toxicity of docetaxel in combination with prednisolone in Japanese patients with hormone refractory prostate cancer." | 1.36 | Docetaxel in combination with prednisolone for hormone refractory prostate cancer. ( Ide, H; Kikuchi, E; Kono, H; Miyajima, A; Nagata, H; Nakagawa, K; Nakashima, J; Ohigashi, T; Oya, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, AW | 1 |
| Hale, P | 1 |
| Rathi, N | 1 |
| Agarwal, N | 1 |
| Ide, H | 1 |
| Kikuchi, E | 1 |
| Kono, H | 1 |
| Nagata, H | 1 |
| Miyajima, A | 1 |
| Nakagawa, K | 1 |
| Ohigashi, T | 1 |
| Nakashima, J | 1 |
| Oya, M | 1 |
| Kaprin, AD | 1 |
| Gafanov, RA | 1 |
| Al'bitskiĭ, IA | 1 |
| Fastovets, SV | 1 |
| Miura, N | 1 |
| Numata, K | 1 |
| Kusuhara, Y | 1 |
| Shirato, A | 1 |
| Hashine, K | 2 |
| Sumiyoshi, Y | 1 |
| Nishimura, K | 1 |
| Nonomura, N | 1 |
| Kanayama, HO | 1 |
| Ozono, S | 1 |
| Miura, T | 1 |
| Miki, T | 1 |
| Kakehi, Y | 1 |
| Arai, Y | 1 |
| Ogawa, O | 1 |
| Fujita, R | 1 |
| Nonomura, K | 1 |
| Mizokami, A | 1 |
| Hoshi, S | 1 |
| Akaza, H | 1 |
| Cameron, DA | 1 |
| Gregory, WM | 1 |
| Bowman, A | 1 |
| Anderson, ED | 1 |
| Levack, P | 1 |
| Forouhi, P | 1 |
| Leonard, RC | 1 |
| Norman, MR | 1 |
| Harmon, JM | 1 |
| Thompson, EB | 1 |
1 review available for prednisolone and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancer.
Topics: Androgen Antagonists; Androgens; Androstenes; Antineoplastic Agents, Hormonal; Antineoplastic Combin | 2017 |
3 trials available for prednisolone and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
[Combined treatment of metastatic hormone-resistant prostate cancer].
Topics: Aged; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chem | 2009 |
Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxe | 2010 |
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug- | 2013 |
3 other studies available for prednisolone and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Docetaxel in combination with prednisolone for hormone refractory prostate cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Respons | 2010 |
Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma; Chemotherapy, A | 2000 |
Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line; Clone Cells; Drug Interactions | 1978 |